Company · CIK 1850119
Century Therapeutics, Inc.
| CIK | 1850119 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | PA |
| Listed | IPSC (Nasdaq) |
| First annual or quarterly report | 2021-08-12 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-288616 | 2025-07-10 | 2026-03-26 | 3 | |
| 333-293228 | 2026-02-05 | 2026-02-17 | 2 | |
| 333-280310 | 2024-06-18 | 2024-06-26 | 2 | |
| 333-279422 | 2024-05-15 | 2024-05-21 | 2 | |
| 333-265975 | 2022-07-01 | 2022-07-13 | 2 | |
| 333-256648 | 2021-05-28 | 2021-06-21 | 5 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-26 | 424B5Shelf takedown | 333-288616 | 0001104659-26-035255 |
| 2026-02-17 | EFFECTDeclared effective | 333-293228 | 9999999995-26-000612 |
| 2026-02-05 | S-3Shelf registered | 333-293228 | 0001104659-26-010885 |
| 2026-01-09 | EFFECTDeclared effective | 333-288616 | 9999999995-26-000127 |
| 2025-07-10 | S-3Shelf registered | 333-288616 | 0001104659-25-067022 |
| 2024-06-26 | EFFECTDeclared effective | 333-280310 | 9999999995-24-001977 |
| 2024-06-18 | S-3Shelf registered | 333-280310 | 0001104659-24-072855 |
| 2024-05-21 | EFFECTDeclared effective | 333-279422 | 9999999995-24-001609 |
| 2024-05-15 | S-3Shelf registered | 333-279422 | 0001104659-24-061899 |
| 2022-07-13 | EFFECTDeclared effective | 333-265975 | 9999999995-22-002060 |
| 2022-07-01 | S-3Shelf registered | 333-265975 | 0001104659-22-076807 |
| 2021-06-21 | 424B4Final prospectus | 333-256648 | 0001104659-21-082886 |
| 2021-06-17 | EFFECTDeclared effective | 333-256648 | 9999999995-21-002398 |
| 2021-06-15 | S-1/AAmendment | 333-256648 | 0001104659-21-081561 |
| 2021-06-14 | S-1/AAmendment | 333-256648 | 0001104659-21-080429 |
| 2021-05-28 | S-1Registration filed | 333-256648 | 0001104659-21-074278 |
| 2021-03-26 | DRSDraft made public | 377-04523 | 0001104659-21-042551 |